In-depth analysis of the critical issues impacting the full spectrum of the pharmaceutical manufacturing value chain.
A recent analysis by Battelle and the Biotechnology Industry Organization (BIO), released last week at the BIO International Convention in San Diego, shows continued growth for the US biosciences industry. A study analyzing US bioscience industry...
The European Investment Bank is teaming with the Belgian biopharmaceutical company UCB in a new model for financing research and innovation projects in the European Union.
Research and development (R&D) represent the lifeblood of the...
The pharmaceutical industry has intensified its new product development efforts in biologics, but has it paid off? A look at the most successful biologic-based drugs launched over the past five years.
As the industry gathers this week for the...
A recent analysis by Ernst & Young concludes that the era of big data has arrived, but are pharmaceutical companies ready?
So what is the next gamechanger for the pharmaceutical value chain? Answer: big data. A recent analysis by Ernst &...
In the wake of not realizing a possible combination with AstraZeneca, Pfizer faces a fundamental question: what is next for the company?
When Pfizer announced in late May that it would not make a formal offer to acquire AstraZeneca following...
As the pharmaceutical industry approaches the first anniversary of the July implementation date of the European Union's (EU) Falsified Medicines Directive, what has been the impact for stakeholders involved in the supply of active pharmaceutical...
Merck & Co, Bristol-Myers Squibb, Roche, and AstraZeneca are among the companies advancing anti-PD-1 and anti-PD-L1 inhibitors in their pipelines.
Oncology is an important area of drug development for pharmaceutical companies, so what is the...
How does sustainability fit into overall investment decisions and practices? Is it a way to achieve competitive advantage? A recent PwC analysis says "yes" as it examines the role of sustainability in financial decision-making.
What is the...
The BRIC (Brazil, Russia, India, and China) countries are important engines of growth for the global pharmaceutical industry, but how does manufacturing activity align with that growth? A look into Russia's pharmaceutical market and the...
Franco Negron, Senior Vice President, North America Commercial Operations & Global Integration, Patheon, discusses the company's rationale for DPx Holdings B.V., formed from the merger of DSM Pharmaceutical Products and Patheon, the integration...
